Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Ziopharm.
Recruitment status was  Active, not recruiting
Memorial Sloan Kettering Cancer Center
Information provided by (Responsible Party):
Ziopharm Identifier:
First received: April 8, 2010
Last updated: January 29, 2013
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: May 2013
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)